Open AccessIncreased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy
Author(s) -
Anna Suy,
Estebán Martínez,
O. Coll,
Montserrat Loncá,
M. Palacio,
Elisa de Lazzari,
María Larrousse,
Ana Milinkovic,
Sandra Hernández,
José Luis Santiago Blanco,
Josép Mallolas,
Agathe León,
Juan A. Vanrell,
José M. Gatell
Publication year - 2006
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/01.aids.0000198090.70325.bd
Subject(s) - medicine , eclampsia , maternal death , obstetrics , odds ratio , pregnancy , gestation , confidence interval , fetus , gynecology , population , genetics , environmental health , biology
Pre-eclampsia and/or fetal death have increased sharply in HIV-infected pregnant women receiving HAART.